| Business Summary | | Lark
Technologies,
Inc.
is
a
provider
of
contract
molecular
biology
services
to
the
pharmaceutical,
biotechnology
and
agbio
industries.
The
Company's
services
are
used
worldwide
by
research
organizations
and
drug
development
institutions
to
accelerate
their
efforts
in
bringing
products
to
the
market.
The
Company's
contract
research
service
portfolio
consists
of
over
100
different
molecular
biology
services
in
the
areas
of
Nucleic
Acid
Extraction
Services,
DNA
Sequencing
Services,
Genetic
Stability
Testing
Services,
Gene
Expression
and
Detection
Services,
and
Custom
Molecular
Biology
Services. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Lark
Technologies,
Inc.
is
a
provider
of
contract
molecular
biology
services
to
the
pharmaceutical,
biotechnology
and
agbio
industries,
including
nucleic
acid
extraction,
DNA
sequencing,
genetic
stability
testing
and
other
services.
For
the
six
months
ended
6/30/01,
revenues
rose
15%
to
$3.1
million.
Net
loss
totaled
$193
thousand
vs.
an
income
of
$25
thousand.
Results
reflect
growth
from
the
quick
turnaround
and
GMO
segments,
offset
by
lower
gross
margins. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| George Britton, 53 Co-Chairman | -- | David Lawson, 53 Co-Chairman | -- | Carl Balezentis, Ph.D., 43 CEO,
Director | $72K | Richard Carlucci Sr.
VP of Sales and Marketing | -- | Gail Morton, 53 VP
of Sales | 106K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|